OTC Markets Group Welcomes Bayer AG to OTCQX
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bayer AG (Frankfurt Stock Exchange: BAYN; OTCQX: BAYRY, BAYZF), a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science, has qualified to trade on the OTCQX® Best Market. Bayer AG upgraded to OTCQX from the Pink® market.
Bayer AG begins trading today on OTCQX under the symbols 'BAYRY' and 'BAYZF.' U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
10 hours ago
- Cision Canada
Oxipital AI and Schmalz Extend Partnership to Deliver Advanced Automated Solutions
BEDFORD, Mass., June 2, 2025 /CNW/ -- Oxipital AI, a leading provider of AI-powered machine vision systems, is proud to welcome Schmalz into its Preferred Partner Program and to continue its long-standing collaboration with the company. Through the integration of Oxipital AI's advanced vision-guided inspection and robotic picking technology with Schmalz mGrip ® finger grippers and vacuum end-of-arm tooling, this partnership is delivering next-generation robotic grasping solutions that enhance operational efficiency, reduce labor reliance, and ensure consistent, safe, and profitable production for end customers in the food & beverage industry and beyond. "Schmalz has worked with Oxipital AI since its inception, so joining their preferred partner program was the logical next step in our ongoing relationship," said Volker Schmitz, President & CEO of Schmalz North America. "Both of our organizations focus on robotic automation, so there were inherent synergies from the start. Pairing our tooling with Oxipital AI vision technologies has enabled us to provide our customers with more capable and higher performing picking solutions that we couldn't offer in the past." "Working with Schmalz has been incredibly easy and fruitful for both companies, combining expertise from both teams to ultimately provide the customer with market-leading automated solutions," said Mark Chiappetta, President & CEO at Oxipital AI. "Schmalz engineers are experts in designing and deploying capable tooling solutions into complex robotic handling applications. Paired with Oxipital AI's vision technology, the Schmalz team will be able to expand the applicability of their solutions to increasingly challenging manufacturing processes. We are excited to expand our existing relationship and look forward to many years of continued collaboration." About Oxipital AI Oxipital AI is a leader in AI-enabled machine vision technologies for quality product inspection and robotic guidance in critical industries such as food processing, agriculture, and consumer goods production. The company's mission is to deliver actionable insights through deep object understanding to customers as they embrace Industry 5.0 and unlock previously unachievable levels of resiliency, efficiency, and sustainability in their manufacturing operations. More information can be found at About Schmalz Schmalz is the global market leader in vacuum industrial automation and ergonomic material handling solutions. With more than 10,000 components, the Vacuum Automation unit includes suction cups and vacuum generators, as well as complete robotic gripping systems and clamping solutions for holding workpieces, for example, in CNC machining centers. The Handling Systems unit offers innovative handling solutions with vacuum lifters, servo hoists and workstation crane systems for industrial material handling applications. The Intelligent Factory solutions make production and logistics processes more flexible, productive and efficient, while also preparing them for the increasing trend toward digitalization. Schmalz now offers more packaging, food and pharma, ergonomic and robotic solutions, thanks to our investment in new technologies and the acquisition of products from Binar Handling, Palamatic and mGrip. For more information, visit our website at
Cision Canada
11 hours ago
- Cision Canada
Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
VANCOUVER, BC, June 2, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the"Company"), reported financial results for the 2024 fiscal year ended December 31, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile. "2024 was a defining year for Else Nutrition, marked by significant challenges that ultimately led to pivotal decisions shaping our future," commented Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "While we encountered major headwinds, including funding constraints, inventory shortages, and a limited marketing budget, we took decisive actions to secure our future. Specifically, we optimized operations, significantly reduced overhead costs, and secured essential funding. We also streamlined our cost structure by cutting underperforming roles, reducing low-ROI marketing spend, and exiting unprofitable retail partnerships. In addition, we restructured R&D operations, including the closure of our Israel lab, to preserve innovation capacity while improving financial performance. Furthermore, we plan to expand our manufacturing and prepare our powder formula in Europe, which will lower production costs, improve margins, and enhance product quality." "Despite our challenges, we made important progress including successfully launching our first Adult Ready-to-Drink (RTD) product, expanding retail placement for our Kids RTD product, and increasing our presence in the U.S. through e-commerce platforms. These milestones reflect the growing demand for plant-based, allergen-friendly nutrition, and we intend to capitalize on these opportunities." "On the regulatory front, we are encouraged by the FDA and HHS's launch of Operation Stork Speed, an initiative aimed at expanding infant formula options and strengthening supply chain resilience. Through our continued bipartisan advocacy efforts, we aim to make significant progress toward modernizing FDA guidelines for plant-based, non-soy, non-dairy infant formula. We look forward to working closely with regulators to establish a clear pathway, ensuring that parents have access to safe, high-quality, and scientifically backed nutrition alternatives." "Furthermore, we were recently featured in an op-ed published in The Washington Times, titled " Operation Stork Speed will ensure babies get the nutrition they need." The piece highlights the importance of accelerating access to clean-label, plant-based alternatives and aligns with our broader mission and ongoing advocacy efforts in Washington to promote science-backed updates to infant nutrition guidelines." "Looking ahead to 2025, we are focused on expanding our retail distribution, scaling our European production, and enhancing brand visibility through targeted marketing and strategic partnerships. With a solid foundation in place, Else Nutrition is well-positioned for long-term growth, and we remain committed to delivering clean-label, plant-based nutrition solutions that meet the needs of families worldwide." 2024 Fiscal Year Financial Results All figures are in CAD unless otherwise indicated. Revenue for 2024 decreased approximately 14.8% to $8 million compared to $9.4 million for 2023. Operating expenses for 2024 was $13.6 million, a decrease of 20% compared to $16.9 million for 2023 Cash balance as of December 31, 2024, was $0.3 million (including restricted cash). Conference Call Else Nutrition management plans to host a business update conference call Tuesday, June 3 rd at 10:00 a.m. Eastern Time to discuss the Company's financial results for the 2024 fiscal year ended December 31, 2024, as well as the Company's corporate progress and other developments. The conference call will be available via telephone by dialing toll free 1-877-407-9219 for U.S. callers or +1-412-652-1274 for international callers. A webcast of the call may be accessed at or on the Investor Relations section of the Company's website at A webcast replay will be available on the Investor Relations section of the Company's website ( through June 3, 2026. A telephone replay of the call will be available approximately three hours following the call, through June 17, 2025, and can be accessed by dialing 1-877-660-6853 for U.S. callers or +1-201-612-7415 for international callers and entering conference ID: 13754118. To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit About Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth. Awards and Recognition: "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category "Best Dairy Alternative" Award 2021 at World Plant-Based Expo Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named Among the Best in Family-Friendly Products by the Prestigious Mom's Choice Awards® TSX Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking Statements This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. SOURCE Else Nutrition Holdings Inc.
![Trulieve Launches "Roll-Up for Justice" Campaign to Support Mission [Green]](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Farticle_placeholder_thumbnail.2d5792c9.png&w=3840&q=100)
Cision Canada
15 hours ago
- Cision Canada
Trulieve Launches "Roll-Up for Justice" Campaign to Support Mission [Green]
TALLAHASSEE, Fla., June 2, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the "Roll-Up for Justice" campaign to support Mission [Green], a national initiative to support individuals disproportionately impacted by cannabis prohibition. Throughout June and July, Trulieve customers in Arizona, Connecticut, Florida, Georgia, and Maryland can support Mission [Green] by rolling up purchases to the nearest dollar. "We're thankful for Trulieve's support of Mission [Green] and our fight to free those still paying the price for outdated cannabis laws," said Weldon Angelos, founder of Mission [Green]. "Together, we can turn spare change into real change." Angelos, a former music producer sentenced to 55 years in prison for selling less than $1,000 of cannabis in 2003, founded Mission [Green] to provide relief for those negatively impacted by cannabis prohibition through clemency and expungement efforts, commissary support, and advocacy for legislative reform. "Weldon's personal story illustrates the urgent need for cannabis reform," said Trulieve's Chief Executive Officer Kim Rivers. "We are proud to support Mission [Green]'s efforts through the Roll-Up for Justice campaign." To learn more about the campaign, please visit About Mission [Green] Mission [Green] is a national initiative powered by The Weldon Project, which was created to support individuals disproportionately impacted by cannabis prohibition. The Weldon Project was founded by Weldon Angelos, a former music producer sentenced to 55 years in federal prison for a nonviolent cannabis offense. After receiving a full pardon from President Trump in 2020, Weldon works tirelessly towards criminal justice reform and second-chance advocacy. About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Investor Contact Christine Hersey, Vice President of Investor Relations +1 (424) 202-0210 [email protected] Media Contact Phil Buck, APR, Corporate Communications Manager +1 (406) 370-6226 [email protected] SOURCE Trulieve Cannabis Corp.
